Zobrazeno 1 - 10
of 16
pro vyhledávání: '"SHU-SHENG WU"'
Autor:
Xiao‐Dong Zhu, Ming‐Zhu Huang, Yu‐Sheng Wang, Wan‐Jing Feng, Zhi‐Yu Chen, Yi‐Fu He, Xiao‐Wei Zhang, Xin Liu, Chen‐Chen Wang, Wen Zhang, Jie‐Er Ying, Jun Wu, Lei Yang, Yan‐Ru Qin, Jian‐Feng Luo, Xiao‐Ying Zhao, Wen‐Hua Li, Zhe Zhang, Li‐Xin Qiu, Qi‐Rong Geng, Jian‐Ling Zou, Jie‐Yun Zhang, Hong Zheng, Xue‐Feng Song, Shu‐Sheng Wu, Cheng‐Yan Zhang, Zhe Gong, Qin‐Qin Liu, Xiao‐Feng Wang, Qi Xu, Qi Wang, Jian‐Mei Ji, Jian Zhao, Wei‐Jian Guo
Publikováno v:
Cancer Communications, Vol 42, Iss 4, Pp 314-326 (2022)
Abstract Background There is no consensus on whether triplet regimen is better than doublet regimen in the first‐line treatment of advanced gastric cancer (AGC). We aimed to compare the efficacy and safety of oxaliplatin plus capecitabine (XELOX) a
Externí odkaz:
https://doaj.org/article/3847a66d6c7b4f0a892d3bcfe99399f3
Autor:
De-Sheng Hu, Shu-Sheng Wu, Qun Wang, Wei Wang, Qi-Kai Sun, Yi-Fu He, Da-Bing Huang, Wei Jia, Ya-Jun Zhao
Publikováno v:
Cancer Letters. 503:19-31
Tumor-associated mesenchymal stem cells (MSCs) play a critical role in the growth and metastasis of hepatocellular carcinoma (HCC). However, the mechanism underlying the crosstalk between MSCs and HCC cells is not completely understood. Here, HCC cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c9163176c1420d6f53dc1b7e25f1e21
https://doi.org/10.1016/j.canlet.2021.01.011
https://doi.org/10.1016/j.canlet.2021.01.011
Publikováno v:
Oncology Letters
The present study compared the expression levels of limb-bud and heart (LBH) between gastric intestinal-type adenocarcinoma (GITA) and healthy gastric tissues; with the aim of investigating the possible effect of LBH on the prognosis of patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6813bcddb8cca73f1d5351d5027d1ed
https://doi.org/10.3892/ol.2020.11778
https://doi.org/10.3892/ol.2020.11778
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND Sorafenib, a multiple-target-point kinase inhibitor, has been used as a standard treatment for advanced liver cancer and has shown therapeutic benefits. However, resistance often occurs, prompting the need for identification of synergizing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af74402046f4e7b22e2107657cd5b419
http://europepmc.org/articles/PMC6559000
http://europepmc.org/articles/PMC6559000
Autor:
Hui-Qin Luo, Yi-Fu He, Ying Yan, Shu-Sheng Wu, Xiao-Xiu Hu, Li-Hong Ke, Jia-Yu Niu, Hui-Min Li, Hui-Jun Xu
Publikováno v:
Translational Cancer Research
Background To find the relationship between prostaglandin E receptor 2 (EP2) and epidermal growth factor receptor (EGFR) in esophageal squamous cell carcinoma (ESCC) patients with regional lymph nodes metastasis (pN+) who had undergone curative resec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::839e93a1b8bb8471a63a1150f5cc7401
https://pubmed.ncbi.nlm.nih.gov/35116865
https://pubmed.ncbi.nlm.nih.gov/35116865
Autor:
Jian Chen, Jia‑Yu Niu, Wei Wang, Hui‑Qin Luo, Bing Hu, Li‑Hong Ke, Ying Yan, Yi‑Fu He, Jie He, Shu‑Sheng Wu, Shan‑Bao Cai, Xiao‑Xiu Hu, Chu‑Shu Ji, Yi‑Wei Yao, Hui‑Min Li
Publikováno v:
Oncology Letters. 9:2706-2712
The present study aimed to analyze the clinical characteristics and prognosis-related factors of non-small cell lung cancer (NSCLC) patients with bone metastases at the time of diagnosis. A total of 46 NSCLC patients with skeletal metastases at the t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fbc66b60b87d0f828b0f6daec714831
https://doi.org/10.3892/ol.2015.3081
https://doi.org/10.3892/ol.2015.3081
Autor:
Lihong Ke, Xiaoxiu Hu, Huijun Xu, Hui-qin Luo, Yi-Fu He, Lulu Cao, Wenju Chen, Hui Li, Jiayu Niu, B. Hu, T. Xu, Yu Yan, Yi Sun, Shu‑Sheng Wu, C. Ji, G. Wang
Publikováno v:
Annals of Oncology. 30:iv22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08c87e14c9abc383f54e672ddffc22aa
https://doi.org/10.1093/annonc/mdz155.081
https://doi.org/10.1093/annonc/mdz155.081
Autor:
Yi-Fu He, Huimin Li, Wenju Chen, Jiayu Niu, Huijun Xu, Shu-Sheng Wu, Lihong Ke, Hui-qin Luo, Xiaoxiu Hu, Ying Yan
Publikováno v:
Technology in Cancer Research & Treatment
Objective: The immune makers including CD4+CD25+ T cells, natural killer cells, and T cells subgroup were retrospectively analyzed to find the relationship between apatinib and the immune system in the patients treated with apatinib. Method: Forty-tw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2119a615ed88f333958d82e123d2d7dd
https://doi.org/10.1177/1533033819893667
https://doi.org/10.1177/1533033819893667
Autor:
Yi-Fu He, T. Xu, Huijun Xu, Shu‑Sheng Wu, Wenju Chen, G. Wang, B. Hu, Yu Yan, Lihong Ke, Jiayu Niu, Hui Li, Yi Sun, Lulu Cao, C. Ji, Xiaoxiu Hu, Hui-qin Luo
Publikováno v:
Annals of Oncology. 29:v26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bab70a25762b953bf12b36cbd1f8899
https://doi.org/10.1093/annonc/mdy151.094
https://doi.org/10.1093/annonc/mdy151.094
Publikováno v:
Medical Science Monitor; 6/1/2019, Vol. 25, p4068-4075, 8p, 4 Graphs